People who take the antiviral Paxlovid within the first few days of a COVID-19 infection may have a 25 percent lower risk of developing a number of conditions associated with long COVID-19, according to findings published Nov. 5 in the preprint server medRxiv.
Read the full post on Becker's Hospital Review - Healthcare News
